Acute cigarette smoke exposure impairs proteasome function in the lung

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 303, Issue 9, 2012, Pages

  van Rijt, Sabine H ^a   Keller, Ilona E ^a   John, Gerrit ^b   Kohse, Kathrin ^b   Yildirim, Ali Ö ^b   Eickelberg, Oliver ^a,b   Meiners, Silke ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Chronic obstructive pulmonary disease; Cigarette smoke; Oxidative stress; Protein quality control; Ubiquitin proteasome system

Indexed keywords

CIGARETTE SMOKE; PROTEASOME; REACTIVE OXYGEN METABOLITE; TRYPSIN; UBIQUITIN; UBIQUITINATED PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BRONCHUS MUCOSA; CARBONYLATION; CELL DEATH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION; GLUTATHIONE; HUMANS; LUNG; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLANT PREPARATIONS; PNEUMOCYTES; POLYUBIQUITIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; PROTEIN CARBONYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SMOKE; SMOKING; TOBACCO; UBIQUITINATED PROTEINS;

EID: 84868358100     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00128.2012     Document Type: Article

References (36)

1. Aldini G, Orioli M, Carini M. Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents. Mol Nutr Food Res 55: 1301-1319, 2011.
2. Bader M, Steller H. Regulation of cell death by the ubiquitin-proteasome system. Curr Opin Cell Biol 21: 878-884, 2009.
3. Breusing N, Grune T. Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem 389: 203-209, 2008.
4. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, Group BCR. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370: 741-750, 2007.
5. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276: 30057-30063, 2001.
6. Carrard G, Bulteau AL, Petropoulos I, Friguet B. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 34: 1461-1474, 2002.
7. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111-126, 1985.
8. Ciechanover A, Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40: 427-446, 2003.
9. Dahlmann B. Role of proteasomes in disease. BMC Biochem 8, Suppl 1: S3, 2007.
10. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR. Committee on Nonsmoking Copd and Occupational Health. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182: 693-718, 2010.
11. Farout L, Friguet B. Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid Redox Signal 8: 205-216, 2006.
12. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78: 477-513, 2009.
13. Friguet B, Bulteau AL, Conconi M, Petropoulos I. Redox control of 20S proteasome. Methods Enzymol 353: 253-262, 2002.
14. Gillardon F, Kloss A, Berg M, Neumann M, Mechtler K, Hengerer B, Dahlmann B. The 20S proteasome isolated from Alzheimer's disease brain shows post-translational modifications but unchanged proteolytic activity. J Neurochem 101: 1483-1490, 2007.
15. Gould NS, Min E, Gauthier S, Martin RJ, Day BJ. Lung glutathione adaptive responses to cigarette smoke exposure (Abstract). Resp Res 12: 133, 2011.
16. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386: 463-471, 1997.
17. Herrmann J, Soares SM, Lerman LO, Lerman A. Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease. J Am Coll Cardiol 51: 2003-2010, 2008.
18. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4: 435-459, 2009.
19. Jung T, Grune T. The proteasome and its role in the degradation of oxidized proteins. IUBMB Life 60: 743-752, 2008.
20. Kisselev AF, Callard A, Goldberg AL. Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem 281: 8582-8590, 2006.
21. Kloetzel PM, Ossendorp F. Proteasome and peptidase function in MHCclass-I-mediated antigen presentation. Curr Opin Immunol 16: 76-81, 2004.
22. Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells (Abstract). Resp Res 7: 132, 2006.
23. Kwak J, Workman JL, Lee D. The proteasome and its regulatory roles in gene expression. Biochim Biophys Acta 1809: 88-96, 2011.
24. Lannan S, Donaldson K, Brown D, MacNee W. Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro. Am J Physiol Lung Cell Mol Physiol 266: L92-L100, 1994.
25. Malhotra D, Thimmulappa R, Vij N, Navas-Acien A, Sussan T, Merali S, Zhang L, Kelsen SG, Myers A, Wise R, Tuder R, Biswal S. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med 180: 1196-1207, 2009.
26. Manning EW, Patel MB, Garcia-Covarrubias L, Rahnemai-Azar AA, Pham SM, Majetschak M. Proteasome peptidase activities parallel histomorphological and functional consequences of ischemia-reperfusion injury in the lung. Exp Lung Res 35: 284-295, 2009.
27. Medicherla B, Goldberg AL. Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins. J Cell Biol 182: 663-673, 2008.
28. Meiners S, Eickelberg O. What shall we do with the damaged proteins in lung disease? Ask the proteasome! Eur Resp J, 2012. doi: 10.1183/09031936.00208511.
29. Min T, Bodas M, Mazur S, Vij N. Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema. J Mol Med 89: 577-593, 2011.
30. Mirabella AC, Pletnev AA, Downey SL, Florea BI, Shabaneh TB, Britton M, Verdoes M, Filippov DV, Overkleeft HS, Kisselev AF. Specific cell-permeable inhibitor of proteasome trypsin-like sites selectively sensitizes myeloma cells to bortezomib and carfilzomib. Chem Biol 18: 608-618, 2011.
31. Pickart CM, Eddins MJ. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 1695: 55-72, 2004.
32. Predmore JM, Wang P, Davis F, Bartolone S, Westfall MV, Dyke DB, Pagani F, Powell SR, Day SM. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 121: 997-1004, 2010.
33. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771, 1994.
34. Schlossarek S, Carrier L. The ubiquitin-proteasome system in cardiomyopathies. Curr Opin Cardiol 26: 190-195, 2011.
35. Schwarz K, de Giuli R, Schmidtke G, Kostka S, van Den BM, Kim KB, Crews CM, Kraft R, Groettrup M. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up-or downregulate antigen presentation at nontoxic doses. J Immunol 164: 6147-6157, 2000.
36. Yao HW, Rahman I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol Appl Pharm 254: 72-85, 2011.